LiqTech International, Inc. — 2014 Form 10-K Summary
Reporting period: Fiscal year ended December 31, 2014; filed March 25, 2015. This is an annual report, not a standalone fourth-quarter filing. LiqTech develops and manufactures silicon-carbide filtration products, principally liquid-filtration systems and diesel particulate filters (DPFs), and is phasing out kiln furniture.
Financial performance and position
| Metric | 2014 | 2013 |
|---|---|---|
| Net sales | $14.56 million | $12.83 million |
| Gross profit / margin | $2.10 million / 14.4% | $1.31 million / 10.2% |
| Operating loss | $5.19 million | $6.22 million |
| Net loss attributable to LiqTech | $3.07 million; $0.09 per share | $4.83 million; $0.19 per share |
| Cash used in operating activities | $5.73 million | $2.14 million |
- Liquid-filter sales rose 48% to $7.53 million and represented 52% of sales, compared with 40% in 2013. DPF sales declined 4.5% to $6.62 million; kiln-furniture sales fell to $0.41 million from $0.81 million.
- Operating expenses were $7.29 million, down 3.2%. Higher selling and marketing costs were more than offset by lower non-cash compensation and research and development expense. A $450,000 currency-transaction gain contributed to 2014 other income.
- At year-end, cash was $5.85 million and restricted cash was $0.22 million; working capital was $10.57 million. Current assets were $14.66 million and current liabilities $4.09 million.
- Total liabilities were $4.46 million, including $0.54 million of capital-lease obligations. Provital had no borrowing outstanding on its $0.33 million demand credit line; a separate guarantee facility had approximately $0.23 million of guarantees outstanding.
- Net cash from financing was $10.45 million, mainly reflecting the July 2014 equity offering. Capital expenditures were $0.46 million. The company reported no off-balance-sheet arrangements other than operating leases.
Material changes and unusual items
- LiqTech acquired all of Provital Solutions A/S on July 29, 2014, paying approximately $2.3 million in cash and issuing 4,044,782 shares. The acquisition added automated pool, spa and water-filtration systems and was funded partly by a public offering of 8 million shares that generated about $10.8 million net. Provital was consolidated from the acquisition date.
- The acquisition resulted in reported goodwill of $8.46 million at year-end. Management recorded no 2014 impairment, but the balance depends on Provital meeting expectations. Some acquisition shares are held in escrow subject to revenue and EBITDA targets through 2016.
- The share offering and acquisition issuance increased shares outstanding from 27.21 million at December 31, 2013 to 39.40 million at December 31, 2014.
- Foreign-currency translation reduced other comprehensive income by $2.54 million in 2014. The company also reported a $1.70 million income-tax benefit despite its pretax loss; deferred tax assets include substantial loss carryforwards and are subject to realization estimates.
Outlook, commentary and risks
- No formal company-wide revenue or earnings guidance is provided. Management said cash and other potential funding sources should cover anticipated working capital and capital spending for the foreseeable future, while warning that continued negative operating cash flow or unexpected expenditures could strain resources.
- Management is prioritizing liquid filtration and integrated systems, expanding sales efforts and developing products including UV LED disinfection and compact water-treatment units. It expects returns on higher sales investment may take several quarters.
- After year-end, the company announced a $2.4 million enhanced-oil-recovery system order and a $350,000 marine wastewater-treatment order, both expected to be delivered in 2015. These are orders, not reported 2014 revenue.
- Key risks include recurring operating losses and cash burn; customer concentration and cancellable orders; dependence on key personnel and successful integration of Provital; potential goodwill impairment; access to silicon carbide and other materials; reliance on subcontracted capacity; foreign-exchange exposure; and regulatory, product-liability and environmental risks.
- A 60% owner of LiqTech Italy sued the company’s Danish subsidiary for €750,000. LiqTech says it considers the claim without merit and intends to defend it. The auditor issued an unqualified opinion on the financial statements; the auditor did not attest to internal-control effectiveness. Management concluded disclosure controls and internal controls over financial reporting were effective.
Investor verification priorities
- Reconcile the reported $5.73 million operating cash outflow with working-capital movements and assess the cash runway without relying on equity issuance.
- Review Provital’s actual performance against acquisition earn-out thresholds, integration progress and the assumptions supporting $8.46 million of goodwill.
- Verify the sustainability and margins of liquid-filtration growth, including the acquired business’s contribution, and the outlook for DPF demand.
- Assess dilution and potential dilution from 39.40 million shares outstanding, 7.03 million warrants and 1.96 million options.
- Check the cash-flow statement’s investing outflow: it reports $2,331,116, while MD&A states $2,331,170; confirm the correct figure in the filed statements.
- Monitor the €750,000 LiqTech Italy dispute, collectability of receivables, and the realizability of deferred tax assets.